Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical and immunological analysis of patients with activated phosphoinositide 3-kinase δ syndrome resulting from PIK3CD mutation].

Zhonghua er ke za zhi = Chinese journal of pediatrics - 2 Jan 2017

Tang W J, Wang W, Luo Y, Wang Y P, Li L, An Y F, Gou L J, Ma M S, He T Y, Yang J, Zhao X D, Song H M

Abstract excerpt

Objective: To explore the clinical and immunological features, gene mutations, treatment and prognosis in patients with activated phosphoinositide 3-kinase δ syndrome (APDS) caused by PIK3CD gene heterozygous germline mutation. Method: The data of clinical, immunological phenotype, treatment, and prognosis of 15 patients with APDS, who visited Children's Hospital of Chongqing Medical University, Peking Union...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD4-Positive T-Lymphocytes
Share to Class I Phosphatidylinositol 3-Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytomegalovirus Infections

Share to Epstein-Barr Virus Infections

Share to Herpesvirus 4, Human

Share to Immunoglobulins, Intravenous

Share to Phosphatidylinositol 3-Kinases

Share to Quality of Life

Source

Identifiers

PMID: 28072954
DOI: 10.3760/cma.j.issn.0578-1310.2017.01.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical and immunological analysis of patients with activated phosphoinositide 3-kinase δ syndrome resulting from PIK3CD mutation].PMID 28072954Read ↗

[Clinical and genetic analysis for activated PI3K-δ syndrome by PIK3CD gene mutation].Semantic proximity Read ↗

The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS).Semantic proximity Read ↗

Identification of a novel de novo gain-of-function mutation of PIK3CD in a patient with activated phosphoinositide 3-kinase δ syndrome.Semantic proximity Read ↗

Successful haploidentical hematopoietic stem cell transplantation for activated phosphoinositide 3-kinase δ syndrome: Case report and literature review.Semantic proximity Read ↗

Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: Expanding the phenotypeSemantic proximity Read ↗

Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.Semantic proximity Read ↗

Disorders Related to PI3Kδ Hyperactivation: Characterizing the Clinical and Immunological Features of Activated PI3-Kinase Delta SyndromesSemantic proximity Read ↗

Clinical practice guideline for activated phosphatidyl inositol 3-kinase-delta syndrome in JapanSemantic proximity Read ↗

Multiple presentations of pediatric activated PI3K-delta syndrome: a single-center experience in south-central mainland ChinaSemantic proximity Read ↗

Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype.Semantic proximity Read ↗

Activated PI3Kinase Delta Syndrome—A Multifaceted DiseaseSemantic proximity Read ↗

Clinical Manifestations and Outcomes of Activated Phosphoinositide 3-Kinase δ Syndrome from the USIDNET Cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.